Crestwood Advisors Group LLC Compugen LTD Transaction History

Crestwood Advisors Group LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 Apr 12, 2022	SELL	$2.76 - $4.64 $11,730 - $19,720	-4,250 Reduced 21.28%	15,720 $51,000
Q3 2021 Nov 03, 2021	SELL	$5.8 - $8.02 $4,350 - $6,015	-750 Reduced 3.62%	19,970 $119,000
Q2 2021 Aug 13, 2021	BUY	$6.87 - $9.16 $5,152 - $6,870	750 Added 3.76%	20,720 $172,000
Q1 2021 Apr 21, 2021	BUY	$7.67 - $13.77 $31,830 - $57,145	4,150 Added 26.23%	19,970 $171,000
Q4 2020 Feb 09, 2021	BUY	$12.07 - $17.95 $10,259 - $15,257	850 Added 5.68%	15,820 $192,000
Q3 2020 Oct 06, 2020	BUY	$14.16 - $19.45 $28,320 - $38,900	2,000 Added 15.42%	14,970 $243,000
Q2 2020 Aug 14, 2020	BUY	$6.97 - $17.12 $90,400 - $222,046	12,970 New	12,970 $194,000

13.1M

79.2K

12.7K

Ticker CGEN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 86,624,600
Market Cap $131M
Description
Compugen Ltd., a clinical-stage therapeutic discovery and development company, researches, develops, and commercializes therapeutic and product candidates in Israel, the United States, and Europe. The company's immuno-oncology pipeline consists of COM701, an anti-PVRIG antibody that is in Phase I clinical study used for the treatment of solid tu...

Get notified when there are updates to the investment portfolio of Crestwood Advisors Group LLC, based on Form 13F filings with the SEC.

Stay updated on Crestwood Advisors Group LLC with notifications on news.